460 related articles for article (PubMed ID: 31230909)
61. Mechanistic aspects of reversible methylation modifications of arginine and lysine of nuclear histones and their roles in human colon cancer.
Roy A; Niharika ; Chakraborty S; Mishra J; Singh SP; Patra SK
Prog Mol Biol Transl Sci; 2023; 197():261-302. PubMed ID: 37019596
[TBL] [Abstract][Full Text] [Related]
62. Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation.
Fong JY; Pignata L; Goy PA; Kawabata KC; Lee SC; Koh CM; Musiani D; Massignani E; Kotini AG; Penson A; Wun CM; Shen Y; Schwarz M; Low DH; Rialdi A; Ki M; Wollmann H; Mzoughi S; Gay F; Thompson C; Hart T; Barbash O; Luciani GM; Szewczyk MM; Wouters BJ; Delwel R; Papapetrou EP; Barsyte-Lovejoy D; Arrowsmith CH; Minden MD; Jin J; Melnick A; Bonaldi T; Abdel-Wahab O; Guccione E
Cancer Cell; 2019 Aug; 36(2):194-209.e9. PubMed ID: 31408619
[TBL] [Abstract][Full Text] [Related]
63. Arginine methylation by PRMT2 promotes IFN-β production through TLR4/IRF3 signaling pathway.
Wang J; Hua H; Wang F; Yang S; Zhou Q; Wu X; Feng D; Peng H
Mol Immunol; 2021 Nov; 139():202-210. PubMed ID: 34583098
[TBL] [Abstract][Full Text] [Related]
64. The physiological and pathophysiological role of PRMT1-mediated protein arginine methylation.
Nicholson TB; Chen T; Richard S
Pharmacol Res; 2009 Dec; 60(6):466-74. PubMed ID: 19643181
[TBL] [Abstract][Full Text] [Related]
65. Unique Features of Human Protein Arginine Methyltransferase 9 (PRMT9) and Its Substrate RNA Splicing Factor SF3B2.
Hadjikyriacou A; Yang Y; Espejo A; Bedford MT; Clarke SG
J Biol Chem; 2015 Jul; 290(27):16723-43. PubMed ID: 25979344
[TBL] [Abstract][Full Text] [Related]
66. Protein arginine methyltransferases (PRMTs) as therapeutic targets.
Cha B; Jho EH
Expert Opin Ther Targets; 2012 Jul; 16(7):651-64. PubMed ID: 22621686
[TBL] [Abstract][Full Text] [Related]
67. Arginine methylation and respiratory disease.
Zhang B; Guan Y; Zeng D; Wang R
Transl Res; 2024 Mar; 272():140-150. PubMed ID: 38453053
[TBL] [Abstract][Full Text] [Related]
68. Transient Kinetics Define a Complete Kinetic Model for Protein Arginine Methyltransferase 1.
Hu H; Luo C; Zheng YG
J Biol Chem; 2016 Dec; 291(52):26722-26738. PubMed ID: 27834681
[TBL] [Abstract][Full Text] [Related]
69. The role of protein arginine methyltransferases in kidney diseases.
Zhang C; Zhuang S
Clin Sci (Lond); 2020 Aug; 134(15):2037-2051. PubMed ID: 32766778
[TBL] [Abstract][Full Text] [Related]
70. Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell-Mediated Antitumor Immune Responses.
Fedoriw A; Shi L; O'Brien S; Smitheman KN; Wang Y; Hou J; Sherk C; Rajapurkar S; Laraio J; Williams LJ; Xu C; Han G; Feng Q; Bedford MT; Wang L; Barbash O; Kruger RG; Hwu P; Mohammad HP; Peng W
Cancer Immunol Res; 2022 Apr; 10(4):420-436. PubMed ID: 35181787
[TBL] [Abstract][Full Text] [Related]
71. Protein arginine methylation: Cellular functions and methods of analysis.
Pahlich S; Zakaryan RP; Gehring H
Biochim Biophys Acta; 2006 Dec; 1764(12):1890-903. PubMed ID: 17010682
[TBL] [Abstract][Full Text] [Related]
72. Cellular consequences of arginine methylation.
Lorton BM; Shechter D
Cell Mol Life Sci; 2019 Aug; 76(15):2933-2956. PubMed ID: 31101937
[TBL] [Abstract][Full Text] [Related]
73. Human protein arginine methyltransferases (PRMTs) can be optimally active under nonphysiological conditions.
Lowe TL; Clarke SG
J Biol Chem; 2022 Sep; 298(9):102290. PubMed ID: 35868559
[TBL] [Abstract][Full Text] [Related]
74. Elucidating the role of PRMTs in prostate cancer using open access databases and a patient cohort dataset.
Grypari IM; Pappa I; Papastergiou T; Zolota V; Bravou V; Melachrinou M; Megalooikonomou V; Tzelepi V
Histol Histopathol; 2023 Mar; 38(3):287-302. PubMed ID: 36082942
[TBL] [Abstract][Full Text] [Related]
75. A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases.
Eram MS; Shen Y; Szewczyk M; Wu H; Senisterra G; Li F; Butler KV; Kaniskan HÜ; Speed BA; Dela Seña C; Dong A; Zeng H; Schapira M; Brown PJ; Arrowsmith CH; Barsyte-Lovejoy D; Liu J; Vedadi M; Jin J
ACS Chem Biol; 2016 Mar; 11(3):772-781. PubMed ID: 26598975
[TBL] [Abstract][Full Text] [Related]
76. Using affinity purification coupled with stable isotope labeling by amino acids in cell culture quantitative mass spectrometry to identify novel interactors/substrates of protein arginine methyltransferases.
Morettin A; Bourassa J; Mahadevan K; Trinkle-Mulcahy L; Cote J
Methods; 2020 Mar; 175():44-52. PubMed ID: 31794835
[TBL] [Abstract][Full Text] [Related]
77. Chemical probes for protein arginine methyltransferases.
Li ASM; Li F; Eram MS; Bolotokova A; Dela Seña CC; Vedadi M
Methods; 2020 Mar; 175():30-43. PubMed ID: 31809836
[TBL] [Abstract][Full Text] [Related]
78. Regulation of post-translational protein arginine methylation during HeLa cell cycle.
Kim C; Lim Y; Yoo BC; Won NH; Kim S; Kim G
Biochim Biophys Acta; 2010 Sep; 1800(9):977-85. PubMed ID: 20541591
[TBL] [Abstract][Full Text] [Related]
79. Protein arginine methylation in Saccharomyces cerevisiae.
Low JK; Wilkins MR
FEBS J; 2012 Dec; 279(24):4423-43. PubMed ID: 23094907
[TBL] [Abstract][Full Text] [Related]
80. Proteome-wide analysis of arginine monomethylation reveals widespread occurrence in human cells.
Larsen SC; Sylvestersen KB; Mund A; Lyon D; Mullari M; Madsen MV; Daniel JA; Jensen LJ; Nielsen ML
Sci Signal; 2016 Aug; 9(443):rs9. PubMed ID: 27577262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
